emendrix

Art. 34

Medical Devices Regulation · 32017R0745 · every event for this act · on EUR-Lex

Functionality of Eudamed

2 changes recorded across 2 events, newest first.

in force 2024-07-09 MODIFIED+138 −410

Amended by Regulation (EU) 2024/1860 32024R1860

applies from: unknown (the text changed beyond its dates, so no date that moved can be read as the application date)

dates removed: 2021-03-25

The first paragraph no longer contains the sentence about the implementation plan seeking to ensure Eudamed is fully functional in time for the Commission to publish the paragraph 3 notice by 25 March 2021 and for other deadlines under Article 123 of this Regulation and Article 113 of Regulation (EU) 2017/746 to be met.

The second paragraph changed from referring to the Commission verifying, based on an independent audit report, that Eudamed as a whole has achieved full functionality and meets the specifications, to referring to the Commission verifying, based on independent audit reports, that one or more of the electronic systems referred to in Article 33(2) are functional and meet those specifications.

Cited: Art. 34, v1 · Art. 34, v2

text before / after

02017R0745-2023032002017R0745-20240709

Article 34 Functionality of Eudamed 1. The Commission shall, in collaboration with the MDCG, draw up the functional specifications for Eudamed. The Commission shall draw up a plan for the implementation of those specifications by 26 May 2018. That plan shall seek to ensure that Eudamed is fully functional at a date that allows the Commission to publish the notice referred to in paragraph 3 of this Article by 25 March 2021 and that all other relevant deadlines laid down in Article 123 of this Regulation and in Article 113 of Regulation (EU) 2017/746 are met. 2. The Commission shall, shall inform the MDCG when, on the basis of an independent audit report, inform the MDCG when reports, it has verified that Eudamed has achieved full functionality one or more of the electronic systems referred to in Article 33(2) are functional and Eudamed meets meet the functional specifications drawn up pursuant to paragraph 1. 1 of this Article. 3. The Commission shall, after consultation with the MDCG and when it is satisfied that the conditions referred to in paragraph 2 have been fulfilled, publish a notice to that effect in the Official Journal of the European Union.

in force 2020-04-24 DEFERRED

Amended by Regulation (EU) 2020/561 32020R0561

applies from: 2021-03-25

dates added to the text: 2021-03-25 · dates removed: 2020-03-25

The only change is the date by which the Commission's implementation plan must allow the notice under paragraph 3 to be published, shifting from 25 March 2020 to 25 March 2021.

Cited: Art. 34, v1 · Art. 34, v2

text before / after, on the event page →